AAM’s core mission is to improve patients’ lives by advancing timely access to affordable, FDA-approved generic and biosimilar medicines. AAM is the nation’s leading trade association for manufacturers and distributors of generic and biosimilar prescription medicines. Our members provide more than 36,000 jobs at nearly 150 facilities, and manufacture more than 61 billion doses of prescription medicine in the US annually.
- Rate-setting laws may work for public utilities, but not for prescription medicines.
- States have no more authority to enact “rate setting” laws than “price fixing” laws.
- Rate-setting laws could limit treatment options.
- Price controls will exacerbate drug shortages.